Tag: Daratumumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Daratumumab

CD38/48 Upregulation With Tazemetostat May Overcome Daratumumab Resistance in ... - OncLive

Added to Collection on: 2023-09-29 23:38:39

Tags for this article:

Clusters of differentiation
Orphan drugs
Immune system
Breakthrough therapy
CD38
Glycoproteins
Daratumumab
EZH2
Multiple myeloma
Demethylase
Antibody-dependent cellular cytotoxicity
CD48
Jiye Liu

Click the tags to see associated articles and topics

View Article Details
[Updated] CD38 Monoclonal Antibodies Market 2023 | Revenue Analysis and Industry Forecast

Added to Collection on: 2023-09-29 18:44:13

Tags for this article:

Immunology
Orphan drugs
Glycoproteins
Biotechnology
CD38
Isatuximab
Daratumumab
Monoclonal antibody
Antibody

Click the tags to see associated articles and topics

View Article Details
Secondary Pure Red Cell Aplasia During Daratumumab/ Hyaluronidase Therapy for ...

Added to Collection on: 2023-10-17 18:09:10

Tags for this article:

Hematopathology
Blood disorders
Autoimmune diseases
Stem cells
Hematology
Daratumumab
Pure red cell aplasia
Multiple myeloma
Aplastic anemia
CD38
Bone marrow
Hematopoietic stem cell transplantation
Nivolumab

Click the tags to see associated articles and topics

View Article Details
Quadruplet Trials Form New Standard in Transplant-Eligible Multiple Myeloma

Added to Collection on: 2024-01-09 22:55:24

Tags for this article:

Orphan drugs
Daratumumab
Multiple myeloma
Daratumumab/hyaluronidase
Dexamethasone
Bortezomib
Lenalidomide

Click the tags to see associated articles and topics

View Article Details
Relapsing/Refractory Multiple Myeloma Market to Observe Stupendous Growth by 2032 ...

Added to Collection on: 2024-01-25 22:02:47

Tags for this article:

Orphan drugs
Elotuzumab
Multiple myeloma
Celgene
AbbVie
Pomalidomide
Lenalidomide
Amgen
Carfilzomib
Bortezomib
Daratumumab
Selinexor

Click the tags to see associated articles and topics

View Article Details
Patient-Centric Care in R/R MM - Cancer Network

Added to Collection on: 2024-02-01 21:43:26

Tags for this article:

Orphan drugs
Multiple myeloma
Daratumumab/hyaluronidase
Daratumumab
Teclistamab
Talquetamab
Idecabtagene vicleucel
Genmab
Isatuximab

Click the tags to see associated articles and topics

View Article Details
Genmab A/S (NASDAQ:GMAB) Upgraded to Outperform by BMO Capital Markets

Added to Collection on: 2024-02-25 14:56:18

Tags for this article:

Stock market
Genmab
Equity securities
Daratumumab
Penny stock
Stock
Genmab A/S

Click the tags to see associated articles and topics

View Article Details
Isa-EloPD Shows Promise in Multiple Myeloma Management - Targeted Oncology

Added to Collection on: 2024-02-28 18:07:51

Tags for this article:

Orphan drugs
Elotuzumab
Isatuximab
Multiple myeloma
Cereblon E3 ligase modulator
Lenalidomide
Pomalidomide
CD38
Selinexor
Daratumumab
Dexamethasone

Click the tags to see associated articles and topics

View Article Details
U.S. FDA Approves Bristol Myers Squibb and 2seventy bio'sAbecma for Triple-Class ...

Added to Collection on: 2024-04-06 13:28:46

Tags for this article:

Orphan drugs
Idecabtagene vicleucel
Multiple myeloma
Elotuzumab
Carfilzomib
Pomalidomide
Lenalidomide
CAR T cell
Daratumumab
Ixazomib
Bristol-Myers Squibb
2SEVENTY BIO, INC.
United States
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Rapid Review Quiz: Systemic Amyloidosis - Page 2 - Medscape Reference

Added to Collection on: 2024-04-05 20:02:48

Tags for this article:

Amyloidosis
Antineoplastic drugs
Protein folding
AL amyloidosis
Chemotherapy
Cyclophosphamide
Daratumumab
Lenalidomide
Carfilzomib
Therapy
Multiple myeloma
Proteinopathy

Click the tags to see associated articles and topics

View Article Details